Targacept, Inc.

(NASDAQ:TRGT)

1.63

-0.82 (-33.47%)

Dec 01 - Close

Open
2.45
High
2.49
Low
1.63
Vol.
34.80K
Mkt Cap
61.16M
52Wk High
10.11
52Wk Low
1.40
Avg. Vol.
34.40K
P/E (Trailing)
-1.36
Beta
1.45
Short %
2.70%
Div. Yield
—

After-Hours 2.67 +1.04 (63.80%) Mon, 1 Dec 2008 6:50 PM

Company Profile

Targacept, Inc.

200 East First Street

Winston-Salem, -2 27101

United States - Map

Phone: (336) 480-2100

Fax: (336) 480-2107

Website: www.targacept.com

CEO: Dr. J. Donald deBethizy, Ph.D.

Employees: 100

Sector: Healthcare

Industry Group: Drugs

Industry: Biotechnology

Biopharm. co. focused on central nervous system

A biopharmaceutical company engaged in the design, discovery and development of NNR Therapeutics(tm), a new class of drugs for the treatment of multiple diseases and disorders of the central nervous system.

Recent news for TRGT

Recent opinions on TRGT

No recent Opinions for TRGT

Top members owning TRGT

Members owning TRGT also own

ABB (100.00%), BRK.A (100.00%), AEE (100.00%), BRK.B (100.00%), AIG (100.00%)

Member sentiment: Neutral